M
Matthew F. Kohler
Researcher at University of California, Irvine
Publications - 8
Citations - 607
Matthew F. Kohler is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Gynecologic oncology & Radiation therapy. The author has an hindex of 8, co-authored 8 publications receiving 578 citations. Previous affiliations of Matthew F. Kohler include Memorial Hospital of South Bend.
Papers
More filters
Journal ArticleDOI
Malignant germ cell tumors of the ovary.
Krishnansu S. Tewari,Fabio Cappuccini,Philip J. DiSaia,Michael L. Berman,Alberto Manetta,Matthew F. Kohler +5 more
TL;DR: It is confirmed that platinum-based adjuvant treatments allow most women with ovarian germ cell malignancies to have conservative surgery without compromising survival.
Journal ArticleDOI
Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus
S. Diane Yamada,Robert A. Burger,Wendy R. Brewster,Deborah Anton,Matthew F. Kohler,Bradley J. Monk +5 more
TL;DR: In this article, the authors determine clinicopathologic variables associated with extrauterine disease, recurrence, and survival in patients with carcinosarcoma (CS) of the uterus.
Journal ArticleDOI
Management of Ovarian Cancer in Patients Older Than 80 Years of Age
Noelle Gillette Cloven,Alberto Manetta,Alberto Manetta,Michael L. Berman,Michael L. Berman,Matthew F. Kohler,Matthew F. Kohler,P.J. DiSaia,P.J. DiSaia +8 more
TL;DR: In patients older than 80 years of age who undergo debulking surgery for ovarian cancer, serious medical comorbidity and advanced ASA status are common and impressive morbidity and mortality occurs in this group of patients, but most patients are discharged to home and are able to receive postoperative chemotherapy.
Journal ArticleDOI
Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer.
Noelle Gillette-Cloven,Robert A. Burger,Bradley J. Monk,D. Scott McMeekin,Steven A. Vasilev,Philip J. DiSaia,Matthew F. Kohler +6 more
TL;DR: In this paper, the authors conducted a study to determine the morbidity and survival associated with bowel resection at the time of primary cytoreductive surgery for ovarian cancer diagnosed between 1983 and 1995.
Journal ArticleDOI
A Phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix : A gynecologic oncology Group study
Katherine Y. Look,John A. Blessing,Charles F Levenback,Matthew F. Kohler,Weldon Chafe,Lynda D. Roman +5 more
TL;DR: The schedule of CPT-11 exhibits modest activity with moderate toxicity in patients with recurrent squamous carcinoma of the cervix, with a overall response rate of 13.3% and 1 patient death from GI toxicity.